🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: perindopril, indapamide , amlodipine

Found 19 matching trials

Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine

PHASE4

PRECIOUS Study aims to evaluate the efficacy and safety of therapy with fix...

Status

Completed

Location

Unimed medical center

Start Date

2018-02-13

Trial ID

NCT03738761

Treatments Being Tested

Amlessa®Co-Amlessa®

Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India

PHASE4

Hypertension is a leading cause of morbidity and mortality globally. Althou...

Status

Completed

Location

Lalitha Super Specialities Hospital

Start Date

2022-08-30

Trial ID

NCT05683301

Treatments Being Tested

Amlodipine + Perindopril Perindopril + Indapamide Amlodipine + Indapamide

Once-daily Fixed Combination of Three Antihypertensive Drugs

PHASE4

Randomized comparison of once-daily fixed combiNation versus free-drug comb...

Status

Unknown

Location

University La Sapienza

Start Date

2016-04

Trial ID

NCT02710539

Treatments Being Tested

perindopril, indapamide , amlodipine Tripliam (perindopril, indapamide, amlodipine)

Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions

PHASE1

This is an open-labeled, randomized, two period, single-center, crossover, ...

Status

Unknown

Location

Ligand Research LLC

Start Date

2023-06-24

Trial ID

NCT05940909

Treatments Being Tested

Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet

Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers

PHASE1

The present study is a comparative bioavailability study performed to asses...

Status

Completed

Location

International Pharmaceutical Research Center

Start Date

2021-05-30

Trial ID

NCT05470764

Treatments Being Tested

PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg amlodipine tablets TRIPLIXAM® 10 mg /2.5 mg/10 mg, 10 mg perindopril arginine / 2.5 mg indapamide / 10 mg amlodipine film-coated tablets

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

N/A

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus res...

Status

Completed

Location

University of Utah

Start Date

2020-01-19

Trial ID

NCT04467931

Treatments Being Tested

ACEI/ARB Non-ACEI/ARB ACEI ARB

Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)

N/A

This is a multi-centre, observational, ambispective study, which will retro...

Status

Completed

Location

Servier

Start Date

2024-05-01

Trial ID

NCT06259175

Treatments Being Tested

Amlodipine 5 mg + indapamide 1.25 mg + perindopril 5 mg Amlodipine 5 mg + indapamide 2.5 mg + perindopril 10 mg Amlodipine 10 mg + indapamide 2.5 mg + perindopril 10 mg

Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

N/A

The main objective of this study is to record, in routine clinical practice...

Status

Completed

Location

Ippokratio University Hospital of Athens

Start Date

2015-11-25

Trial ID

NCT02655029

Treatments Being Tested

Perindopril/Indapamide/Amlodipine fixed dose combination

Optimal Medical Treatment of Difficult-to-treat Hypertension

PHASE4

The purpose of this study is to evaluate best medical management to achieve...

Status

Unknown

Location

National Institute of Cardiology

Start Date

2023-10-20

Trial ID

NCT06275763

Treatments Being Tested

Phase C: Eplerenone Phase C: Spironolactone Phase C: Torasemide Phase B: Triplixam / Elestar HCT Phase A: Confirmation of uncontrolled hypertension

Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension

PHASE3

The purpose of this study is to investigate the efficacy and safety of a fi...

Status

Completed

Location

China-Japan Friendship Hospital

Start Date

2019-05-06

Trial ID

NCT05820880

Treatments Being Tested

Fixed [Per/Ind/Aml]Free [Per/Ind + Aml]

Previous Next